Precise regulation of the properties of hydrophobic carbon dots by manipulating the structural features of precursor ionic liquids

Ionic liquid-based carbon dots as highly biocompatible and sensitive fluorescent probe for the determination of vitamin P in fruit samples

Vitamin P (VP) known as rutin is one of the common flavonoids, which widely exists in fruits and vegetables and often used as a dietary additive. The rapid and accurate detection of VP in food matrices is critical for evaluating food quality and guiding diet. Herein, a rapid, accurate, and selective detection scheme for VP in fruit samples was proposed for the first time using ionic liquid-based carbon dots (IL-CDs). The synthesized IL-CDs exhibited great biocompatibility and excellent optical properties including high fluorescence intensity, high quantum yield, and good fluorescence stability. Through an internal filtering effect (IFE), VP could greatly reduce the fluorescence of these CDs. In the present study, this probe demonstrated good sensitivity and excellent selectivity toward VP with a low detection limit of 60.0 nmol/L. Moreover, this approach was effectively applied to detect VP in food samples with a recovery range of 97 % to 119 %. More interestingly, the results of cell imaging suggested that IL-CDs were expected to be promising material for bioimaging.

Modulation of the binding ability to biomacromolecule, cytotoxicity and cellular imaging property for ionic liquid mediated carbon dots

For the preparation of carbon dots (CDs), a variety of carbon sources and synthetic protocols are available which endow CDs with variable and unpredictable properties. In the present study, three CDs were developed with ionic liquid 1-butyl-3-methylimidazolium dicyanamide as the precursor through ethanol-thermal and hydrothermal strategies, termed as E-CDs and H-CDs, respectively. The features of these carbon dots, i.e., their physicochemical and optical properties, their interactions with bovine serum albumin (BSA) as well as their imaging capability were investigated with respect to the CDs prepared with microwave assisted approach (W-CDs). E-CDs and H-CDs were demonstrated to exhibit similar framework structures and optical properties, and they exhibited larger particle-sizes than that of W-CDs. In addition, the increase of ethanol-thermal and hydrothermal reaction time strengthened the quantum yields of the CDs and promoted their binding capability with BSA. E-CDs and H-CDs showed similar cytotoxicity on normal (LX-2) and cancer (SK-Hep-1) cells. We further found that these CDs may readily enter the cells within 5 min, while the fluorescence of hydrophilic E-CDs and H-CDs was very weak with respect to that of hydrophobic W-CDs in cell imaging. On the other hand, all the CDs exhibited little impact on the level of intracellular reactive oxygen species. The present study is conducive to guide the preparation of suitable carbon dots for different application scenarios.

Carbon Dot Therapeutic Platforms: Administration, Distribution, Metabolism, Excretion, Toxicity, and Therapeutic Potential

Ultrasmall nanoparticles are often grouped under the broad umbrella term of "nanoparticles" when reported in the literature. However, for biomedical applications, their small sizes give them intimate interactions with biological species and endow them with unique functional physiochemical properties. Carbon quantum dots (CQDs) are an emerging class of ultrasmall nanoparticles which have demonstrated considerable biocompatibility and have been employed as potent theragnostic platforms. These particles find application for increasing drug solubility and targeting, along with facilitating the passage of drugs across impermeable membranes (i.e., blood brain barrier). Further functionality can be triggered by various environmental conditions or external stimuli (i.e., pH, temperature, near Infrared (NIR) light, ultrasound), and their intrinsic fluorescence is valuable for diagnostic applications. The focus of this review is to shed light on the therapeutic potential of CQDs and identify how they travel through the body, reach their site of action, administer therapeutic effect, and are excreted. Investigation into their toxicity and compatibility with larger nanoparticle carriers is also examined. The future of CQDs for theragnostic applications is promising due to their multifunctional attributes and documented biocompatibility. As nanomaterial platforms become more commonplace in clinical treatments, the commercialization of CQD therapeutics is anticipated.